13F Holdings
中文EN

CORZW Core Scientific, Inc./tx

Finance Services · Nasdaq · SEC CIK 1839341 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY77.2%
TTM net income YoY86.1%
TTM EPS YoY-650.0%
Revenue 3-yr CAGR7.1%
Net income 3-yr CAGR—

Margins

Gross margin41.2%
Operating margin-73.6%
Net margin-18.6%
FCF margin-223.0%
EBITDA margin-62.8%

Returns

ROE—
ROA-2.7%
ROIC (approx.)-98.4%
Asset turnover0.15x

Leverage & solvency

Liabilities / assets118.4%
Debt / equity—
Current ratio0.67x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-4.08x
Accruals ratio-13.8%
Payout ratio—
Capex / revenue298.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$319.02M$510.67M$502.40M$640.31M$544.48M
Cost of revenue$281.12M$389.60M$378.94M$631.91M$305.62M
Gross profit$37.90M$121.07M$123.46M$8.40M$238.86M
R&D expense—$11.83M$7.18M$26.96M$7.67M
SG&A expense$159.22M$113.69M$108.11M$213.28M$60.49M
Operating income-$245.59M-$142.06M$8.96M-$2.11B$131.49M
Pretax income-$288.03M-$1.44B-$245.80M-$2.16B$63.08M
Income tax$583,000$859,000$683,000-$17.09M$15.76M
Net income-$288.62M-$1.44B-$246.49M-$2.15B$47.31M
EBITDA-$176.68M-$28.86M$104.96M-$1.88B$164.86M
EPS (basic)-0.88-4.87-0.65-6.300.23
EPS (diluted)-0.88-4.87-0.65-6.300.20
Weighted avg. shares (diluted)318.07M255.83M379.86M340.65M233.31M
Balance sheet
Cash & equivalents$311.38M$836.98M$50.41M$52.24M$131.68M
Receivables—$1.02M$1.00M$234,000$1.38M
Current assets$895.54M$903.96M$97.02M$85.10M$756.56M
PP&E, net$1.29B$433.47M$585.43M$691.13M$597.30M
Goodwill——$0$0$1.06B
Intangibles$1.08M—$2.25M$1.70M$8.20M
Total assets$2.35B$1.48B$712.16M$807.69M$2.44B
Current liabilities$781.40M$134.56M$488.42M$186.79M$320.29M
Short-term debt$0————
Long-term debt$1.06B————
Total debt$1.06B————
Total liabilities$3.31B$2.42B$1.31B$1.22B$1.05B
Shareholders' equity-$962.74M-$943.05M-$596.94M-$409.35M$1.34B
Net debt$748.95M————
Shares outstanding314.23M292.61M386.88M375.23M271.58M
Cash flow statement
Operating cash flow$278.25M$42.90M$65.11M$205.19M-$56.73M
Capital expenditure$729.00M$94.96M$16.16M$383.98M$0
Free cash flow-$450.75M-$52.06M$48.95M-$178.79M-$56.73M
Investing cash flow-$740.75M-$95.19M-$3.00M-$590.78M-$423.84M
Financing cash flow-$63.10M$819.57M-$44.65M$306.15M$603.53M
Depreciation & amortization$68.91M$113.20M$96.00M$225.26M$33.36M
Stock-based compensation$98.24M$51.92M$58.89M$182.89M$38.94M
Share buybacks—$0$0$31.65M—

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.